The FDA ruling is based on the results of a series of clinical trials that showed the therapy to be safe and effective. In a trial featuring 101 patients, 82 percent of patients responded to the treatment.
Paul Farmer, MD, PhD, an anthropologist and physician, discusses how community health workers helped Rwanda achieve the steepest declines in mortality ever documented.
Veins deep in the legs and pelvis can harbor a dangerous blood clot known as a deep vein thrombosis (DVT). Learn more about the risk factors, symptoms, and treatment options.
Three researchers are competing for the BRIght Futures Prize, a $100,000 award that will fund an innovative idea in medicine – and you decide who wins.